XML 38 R21.htm IDEA: XBRL DOCUMENT v3.26.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 19, 2024
Dec. 31, 2025
Dec. 31, 2024
Research and development   $ 2,259,796 $ 2,400,777
Warrants [Member]      
Anti-dilutive securities   6,100,719 3,184,809
Options [Member]      
FDIC insured amount   $ 250,000  
Research and development   2,259,796 $ 2,400,777
Deferred revenue   $ 0 $ 40,000
Amendment of increase authorized common stock amendment to our Articles of Incorporation to increase the number of authorized shares of common stock from 5,000,000 to 25,000,000    
Anti-dilutive securities   11,183 11,183